Abstract
There are about 117 000 strokes each year in Germany. The risk of recurrent stroke in survivors is estimated at up to 15%. The cerebral infarction frequently represents the initial clinical manifestation of a generalized atherosclerotic disease bearing an extensive risk of further extracerebral complications. This brief review mentions recent studies that impact clinical practice of secondary prevention including the choice of platelet inhibitors, anticoagulation, interventional therapy of carotid stenosis and management of certain modifiable risk factors.
Translated title of the contribution | Status quo in secondary stroke prevention |
---|---|
Original language | German |
Pages (from-to) | 1117-1122 |
Number of pages | 6 |
Journal | Nervenheilkunde |
Volume | 27 |
Issue number | 12 |
DOIs | |
State | Published - 2008 |